Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration
Launched by JARDING, JOHN, OD · Jan 20, 2023
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged at least 50 years with dry AMD in at least one eye
- Exclusion Criteria:
- • Eye diseases other than dry AMD
- • Implanted electrical devices
- • Seizure disorders
About Jarding, John, Od
Dr. John Jarding, O.D., is a dedicated clinical trial sponsor with extensive experience in ocular research and optometry. Committed to advancing eye care, Dr. Jarding leads innovative studies aimed at evaluating new treatments and interventions for various visual disorders. With a strong emphasis on patient safety and rigorous scientific methodology, he collaborates with multidisciplinary teams to ensure the highest standards of clinical research. Dr. Jarding's expertise not only contributes to the development of effective therapeutic solutions but also enhances the understanding of eye health within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
